Cellect Biotechnology Ltd. (APOP) |
| 13.17 0.05 (0.38%) 10-29 00:00 |
| Open: | 13.12 |
| High: | 13.3188 |
| Low: | 13.1 |
| Volume: | 17,433 |
| Market Cap: | 129(M) |
| PE Ratio: | -15.42 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 29.8 |
| 52w Low: | 1.75 |
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Sat, 22 Aug 2026
Capricor Therapeutics, Inc. - Common Stock (NQ: CAPR - FinancialContent
Mon, 21 Jun 2021
Stocks to Buy: Shares That May See a Big Short Squeeze This Week: Fintel - Business Insider
Mon, 01 Feb 2021
Kadimastem hopes to turn corner with new management - Globes - Israel Business News
Tue, 28 Mar 2017
Cellect soars on Nasdaq after initial trial report - Globes - Israel Business News
Sun, 30 Aug 2026
Sun, 30 Aug 2026
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |